Pediatrik Boyun Kitlelerine Yaklaşım

ÖzÇocuklarda baş-boyun kitleleri gelişimsel, inflamatuvar ve neoplastik olmaküzere  üç kategoriye ayrılır. Tüm pediatrik boyun  kitlelerinde malignite % 10 oranında izlenir. Yapılacak çalışmalar tam kan sayımı, tüberküloz için pürifiye protein derivesi (PPD) testi ve Epstein-Barr virus, sitomegalovirus, HIV, toksoplazmave kedi tırmığı hastalığı etkeni titrelerinin belirlenmesidir. Gelişimsel veya pal-pabl bir kitle için ultrasonografi öncelikli görüntüleme yöntemidir. Şüpheli bakteriyel lenfadenitlerin tedavisi için kullanılacak antibiyotik Staphylococcus aureusve A grubu streptokokları hedeflemelidir. Maligniteden şüphelenildiğinde hastabiyopsi açısından değerlendirilmelidir.

Evaluation And Management Of Pediatric Neck Masses

AbstractHead and neck masses in children fall into one of three categories: develop-mental, inflammatory or neoplastic. Children neck masses require through clinical examination and follow-up to determine the biological nature and course of theabnormality. Malignancy must be considered, as it occurs in 10% of all pediatricneck masses. Work up for a neck mass may include a complete blood count, purified protein derivative (PPD) test for tuberculosis; and measurement of titers for Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus, toxoplasmosis and cat scratch disease. Ultrasonography is preferred imaging study for adevelopmental or palpable mass. Antibiotic therapy for suspected bacterial lymphadenitis should target Staphylococcus aureusand group A streptococcus. Ifmalignancy is suspected, the patient should be evaluated for possible biopsy.

___

  • Kaynaklar 1.Curtis WJ, Edwards SP. Pediatric neck masses. Atlas OralMaxillofac Surg Clin North Am 2015; 23 (1): 15-20. 2.Wetmore RF, Muntz HR, McGill T: Pediatric Otolaryngo-logy: Principles and Practice Oathways. New York, ThiemeMedical Publishers, 2000. 3.Cunningham MJ, Myers EN, Bluestone CD. Malignant tu-mors of the head and neck in children: A twenty-year revi-ew. Int J Pediatr Otorhinolaryngol 1987; 13 (3): 279-92. 4.Bauer PW, Lusk RP. Neck masses. In: Bluestone CD, StoolSE, Alper CM, et al., (eds). Pediatric Otolaryngology. 4thed. Philadelphia: Saunders, 2003: 1629-47. 5.Meier JD, Grimmer JF. Evaluation and management of neckmasses in children. Am Fam Physician 2014; 89 (5): 353-58. 6.Torsiglieri AJ Jr, Tom LW, Ross AJ III, Wetmore RF, HandlerSD, Potsic WP. Pediatric neck masses: guidelines for evaluati-on. Int J Pediatr Otorhinolaryngol 1988; 16 (3): 199-210. 7.Park YW. Evaluation of neck masses in children. Am FamPhysician 1995; 51 (8): 1904-12. 8.Meuwly JY, Lepori D, Theumann N, et al: Multimodalityimaging evaluation of the pediatric neck: Techniques andspectrum of findings. Radiographics 2005; 25: 931-48. 9.American College of Radiology. ACR Appropriateness Criteria. Neckmass/adenopathy.http://www.acr.org/~/media/ACR/Docu-ments/AppCriteria/Diagnostic/NeckMassAdenopathy.pdf.Accessed December 2, 2013. 10.Turkington JR, Paterson A, Sweeney LE, Thornbury GD. Neckmasses in children. Br J Radiol 2005; 788 (925): 75-85. 11.Ramadan HH, Wax MK, Boyd CB. Fine needle aspirationof head and neck masses in children. Am J Otorhinolaryn-gol 1997; 18 (6): 400-404. 12.Mobley DL, Wakely PE Jr, Frable MA. Fine-needle aspira-tion biopsy: application to pediatric head and neck masses.Laryngoscope 1991; 101 (5): 469-72. 13.Anne S, Teot LA, Mandell DL: Fine needle aspiration bi-opsy: role in diagnosis of pediatric head and neck masses.Int J Pediatr Otorhinolaryngol 2008; 72 (10): 1547-53. 14.Dulin MF, Kennard TP, Leach L, Williams R. Managementof cervical lymphadenitis in children. Am Fam Physician2008; 78 (9): 1097-98. 15.Long SS, Pickering LK, Prober CG. Principles and Practi-ce of Pediatric Infectious Diseases, 2nd ed. New York, NY:Churchill Livingstone; 2003. 16.Leung AK, Robson WL. Childhood cervical lymphadeno-pathy. J Pediatr Health Care 2004; 18 (1): 3-7.